MACDONALD LAURA ANN 4

Accession 0001721515-25-000012

CIK 0000851205other

View on SEC.gov Company Profile

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 5:13 PM ET

Size

25.4 KB

Accession

0001721515-25-000012

Insider Transaction Report

Form 4

Period: 2025-02-18

COGNEX CORPCGNX

MACDONALD LAURA ANN

PFO & PAO

Transactions

Award
Non-Qualified Stock Option (right to buy)
2025-02-18+33,168→ 33,168 total
Exercise: $33.04From: 2026-02-18Exp: 2035-02-18→ Common Stock (33,168 underlying)
Award
Restricted Stock Unit
2025-02-18+12,107→ 12,107 total
Exercise: $0.00From: 2026-02-18Exp: 2028-02-18→ Common Stock (12,107 underlying)

Holdings

Restricted Stock Unit
Exercise: $0.00From: 2023-02-22Exp: 2025-02-22→ Common Stock (2,072 underlying)
2,072
Restricted Stock Unit
Exercise: $0.00From: 2024-02-21Exp: 2026-02-21→ Common Stock (4,406 underlying)
4,406
Common Stock
3,765
Common Stock
(indirect: By Children)
20
Non-Qualified Stock Option (right to buy)
Exercise: $38.39From: 2018-02-21Exp: 2027-02-21→ Common Stock (12,500 underlying)
12,500
Non-Qualified Stock Option (right to buy)
Exercise: $39.44From: 2025-02-20Exp: 2034-02-20→ Common Stock (37,698 underlying)
37,698
Non-Qualified Stock Option (right to buy)
Exercise: $47.21From: 2024-02-21Exp: 2033-02-21→ Common Stock (30,492 underlying)
30,492
Non-Qualified Stock Option (right to buy)
Exercise: $48.28From: 2022-05-01Exp: 2029-05-01→ Common Stock (10,000 underlying)
10,000
Non-Qualified Stock Option (right to buy)
Exercise: $50.94From: 2021-02-18Exp: 2030-02-18→ Common Stock (42,500 underlying)
42,500
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (30,000 underlying)
30,000
Non-Qualified Stock Option (right to buy)
Exercise: $56.44From: 2019-02-20Exp: 2028-02-20→ Common Stock (15,000 underlying)
15,000
Non-Qualified Stock Option (right to buy)
Exercise: $64.43From: 2023-02-22Exp: 2032-02-22→ Common Stock (23,891 underlying)
23,891
Non-Qualified Stock Option (right to buy)
Exercise: $90.50From: 2022-02-16Exp: 2031-02-16→ Common Stock (13,946 underlying)
13,946
Restricted Stock Unit
Exercise: $0.00From: 2025-02-20Exp: 2027-02-20→ Common Stock (6,339 underlying)
6,339
Restricted Stock Unit
Exercise: $0.00From: 2025-03-15Exp: 2027-03-15→ Common Stock (1,228 underlying)
1,228

Footnotes (4)

[F1]Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
[F2]The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
[F3]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
[F4]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

COGNEX CORP

CIK 0000851205

→

Entity typeother

Related Parties

filerCIK 0001773704

Filing Metadata

Form type: 4
Filed: Feb 19, 7:00 PM ET
Accepted: Feb 20, 5:13 PM ET
Size: 25.4 KB

View on SEC.gov